McKesson Corporation (MCK.MX)
- Previous Close
8,870.63 - Open
0.00 - Bid --
- Ask --
- Day's Range
8,870.63 - 8,870.63 - 52 Week Range
6,543.00 - 8,871.41 - Volume
0 - Avg. Volume
25 - Market Cap (intraday)
1.195T - Beta (5Y Monthly) 0.45
- PE Ratio (TTM)
23.64 - EPS (TTM)
375.23 - Earnings Date May 7, 2024
- Forward Dividend & Yield 42.52 (0.48%)
- Ex-Dividend Date Jun 3, 2024
- 1y Target Est
--
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
www.mckesson.com45,000
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: MCK.MX
Performance Overview: MCK.MX
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MCK.MX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MCK.MX
Valuation Measures
Market Cap
1.19T
Enterprise Value
1.29T
Trailing P/E
23.62
Forward P/E
16.86
PEG Ratio (5yr expected)
4.96
Price/Sales (ttm)
0.23
Price/Book (mrq)
--
Enterprise Value/Revenue
4.28
Enterprise Value/EBITDA
290.71
Financial Highlights
Profitability and Income Statement
Profit Margin
0.99%
Return on Assets (ttm)
3.63%
Return on Equity (ttm)
--
Revenue (ttm)
301.51B
Net Income Avi to Common (ttm)
3B
Diluted EPS (ttm)
375.23
Balance Sheet and Cash Flow
Total Cash (mrq)
1.98B
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
3.03B
Company Insights: MCK.MX
MCK.MX does not have Company Insights